Pulmonary Embolism in Exacerbations of Chronic Obstructive Pulmonary Disease

Sykehuset Innlandet HF38 enrolled

Overview

The purpose of this study is to determine the prevalence of pulmonary embolism in our population of Chronic Obstructive Pulmonary Disease (COPD) patients admitted to hospital with dyspnea. The patients will undergo investigation for pulmonary embolism, according to current guidelines.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Pulmonary Embolism Chronic Obstructive Pulmonary Disease

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * known or suspected COPD * COPD-exacerbation Exclusion Criteria: * other causes of dyspnea * unable to perform CT pulmonary angio (contrast allergy, pregnancy) * already included in the study (each patient included only once) * use of anticoagulants

Locations (1)

Sykehuset Innlandet

Lillehammer, Oppland, Norway

Outcomes

Primary Outcomes

Prevalence of pulmonary embolism in exacerbations of COPD

Time frame: one year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.